Analysis of TCGA data revealed that RBP7 undergoes frequent genomic alterations across multiple cancer types, with amplification occurring in 0.54% and deletion in 1.34% of HCC cases (Supplementary Figure S1A). Here, RBP7 is linked to hepatocellular carcinoma.